Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PRKCB | P05771 | 4/20 | 0.36 |
| ▸ | PRKCG | P05129 | 3/20 | 0.36 |
| ▸ | PRKCA | P17252 | 3/20 | 0.36 |
| ▸ | PRKCH | P24723 | 3/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25256112 | 1.00 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL25217371 | 1.00 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL30352814 | 1.00 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL4716290 | 0.89 | KDM4E (0.41) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL30614595 | 0.88 | KDM4E (0.40) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL476301 | 0.88 | KDM4E (0.40) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL3882337 | 0.88 | KDM4E (0.40) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL932859 | 0.88 | KDM4E (0.40) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| Methane SCHEMBL28294512 | 0.87 | KDM4E (0.40) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 | |
| SCHEMBL28871836 | 0.81 | GSK3B (0.41) | ALDH1A1KDM4EHPGDHSD17B10MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540126-B2 | Method for preparing oxetan-2-ylmethanamine | ACCELA CHEMBIO CO., LTD. (CN) | 2026-02-03 | — | — | US | disclosed |
| CN-115991685-B | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20240317695-A1 | METHOD FOR PREPARING OXETAN-2-YLMETHANAMINE | ACCELA CHEMBIO CO., LTD. (CN) | 2024-09-26 | — | — | US | disclosed |
| EP-4194446-A1 | PREPARATION METHOD FOR OXETANE-2-METHYLAMINE | ACCELA CHEMBIO CO., LTD. (CN) | 2023-06-14 | — | — | EP | disclosed |
| WO-2023065434-A1 | PREPARATION METHOD FOR OXETANE-2-METHYLAMINE | 韶远科技（上海)有限公司 | 2023-04-27 | — | — | WO | disclosed |
| CN-115991685-A | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2023-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540126-B2 | Method for preparing oxetan-2-ylmethanamine | TH, ALKBH2, ALKBH3 | ALDH1A1 1775/4885KDM4E 207/4885HPGD 2281/4885 |
| US-20240317695-A1 | METHOD FOR PREPARING OXETAN-2-YLMETHANAMINE | TH, TET1, TMT1A | ALDH1A1 1838/4885KDM4E 131/4885HPGD 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.